Skip to main content
. 2021 May 20;62(6):22. doi: 10.1167/iovs.62.6.22

Table 1.

Clinical Data for Bestrophinopathy Patients

Family: Member (Sex) Allele 1/2 (AA Change) Age at Exam (Onset) Initial BCVA Refraction EOG Arden Ratio Color Vision Score (axis) Axial Length (ACD, mm) IOP (mm Hg) C/D GVF
A: III,1 (F) c.103G>A (p.Glu35Lys) 6 (5) OD 20/32 +1.00 +1.50 × 82 1.8 11/15 (D15, nonspecific) 22.17 15 0.40 NA
c.103G>A (p.Glu35Lys) OS 20/80 +1.00 +1.75 × 90 0.88 13/15 (D15, nonspecific) 22.46 15 0.40 NA
B: III,1 (F) c.422G>A (p.R141H) 44 (3) OD 20/320 +0.75 +2.50 × 180 1.64 1/15 (D15, Tritan) 21.35 11 0.40 Paracentral scotoma, constricted I1e, off-center I4e
c.830C>T (p.T277M) OS 20/320 +3.25 +2.25 × 13 Unable 1/15 (D15, Tritan) 21.11 11 0.50 Paracentral scotoma, absent I1e and I2e, and off-center I4e
B: III,2 (F) c.422G>A (p.R141H) 39 (4) OD 20/200 +2.00 +1.23 × 112 NA 3/15 (D15, Tritan) 21.40 15 0.20 Dense central scotoma, absent I1e
c.830C>T (p.T277M) OS 20/640 +2.75 +1.25 × 32 NA 2/15 (D15, Tritan) 21.73 16 0.20 Dense central scotoma, absent I1e
C: II,2 (F) c.671T>A (p.L224Q) 24 (12) OD 20/125 −2.00 Sph NA NA NA 15 1.00 Central scotoma with constriction of I3e, I4e, III4e, and IV4e
c.353A>C (p.D118A) OS 20/800 Sph Plano NA NA NA 17 0.30 Central scotoma with absent I3e and I4e, constricted III4e and IV4e
D: IV,2 (F) c.418C>G (p.L140V) 32 (30) OD 20/80 −0.75 +1.75 × 5 1.12 12/16 (Ishihara) 21.11 40 (22*) 0.60 Central scotoma constriction of I1e, I2e, and I4e
c.418C>G (p.L140V) OS 20/100 −0.25 +1.50 × 10 1.11 11/16 (Ishihara) 20.84 15 0.50 Central scotoma constriction of I1e, I2e, and I4e
E: IV,5 (F) c.816_818delTGT (p.V273del) 26 (4) OD 20/50 −1.25 +1.75 × 101 1.14 12/15 (D15, Tritan) 21.31 (2.15) 20 0.60 Absent I1e and constricted I4e
c.816_818delTGT (p.V273del) OS 20/40 −0.50 +1.25 × 94 1.21 9/15 (D15, Tritan) 21.14 (2.47) 13 0.60 Constricted I1e
F: III,1 (M) c.122T>C (p.Leu41Pro) 9 (9) OD 20/20 +0.50 −0.50 × 168 NA 9/15 (D15, nonspecific) 22.4 (3.44) 21 0.30 NA
c.422G>A (p.Arg141His) OS 20/50 +0.50 −0.25 × 47 NA 13/15 (D15, nonspecific) 22.8 (3.17) 20 0.30 NA
F: III,2 (F) c.122T>C (p.Leu41Pro) 10 (10) OD 20/25 +3.75 −0.75 × 147 NA 11/15 (D15, nonspecific) 21.05 (3.00) 17 0.30 NA
c.422G>A (p.Arg141His) OS 20/20 +3.50 −0.75 × 38 NA 15/15 21.04 (2.92) 16 0.30 NA
G: II,1 (M) c.604C>T (p.Arg202Trp) 23 (23) OD 20/320 −4.50 +2.25 × 97 NA NA NA 14 NA Constricted I4e, I1e absent
c.604C>T (p.Arg202Trp) OS 20/200 −4.50 +0.50 × 170 NA NA NA 25 NA Constricted I4e, I1e absent
H: II,1 (F) c.122T>C (p.Leu41Pro) 60 (31) OD 20/300 +10.50 sph NA NA NA 17 0.30 Central scotoma without constriction
c.122T>C (p.Leu41Pro) OS 20/150 +10.50 sph NA NA NA 14 0.30 Normal in all isopters

AA amino acid, ACD anterior chamber depth, C/D cup-to-disk ratio, GVF Goldmann visual field, NA not assessed.

*

IOP tested after laser peripheral iridotomy treatment for acute angle closure episode.